Updated Jul 16, 2026
Botwood Nicholas A.J. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.18M.
Nicholas A.J. Botwood is associated with Syndax Pharmaceuticals Inc, as indicated by the recent SEC filing. However, there is limited publicly available information about his background and career, suggesting he may not be widely recognized in the public domain.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | SNDX | Syndax Pharmaceuticals Inc | S — Open-market sale | 31.2K | $18.14 | $567K |
| 2026-06-12 | SNDX | Syndax Pharmaceuticals Inc | M — Option exercise | 31.2K | $13.82 | $432K |
| 2026-06-12 | SNDX | Syndax Pharmaceuticals Inc | S — Open-market sale | 34.3K | $18.00 | $617K |
| 2026-06-12 | SNDX | Syndax Pharmaceuticals Inc | M — Option exercise | 22.5K | $13.82 | $311K |
| 2026-02-06 | SNDX | Syndax Pharmaceuticals Inc | A — Grant or award | 36.0K | $0.00 | |
| 2026-02-06 | SNDX | Syndax Pharmaceuticals Inc | A — Grant or award | 24.0K | $0.00 |
Nicholas A.J. Botwood is associated with Syndax Pharmaceuticals Inc, as indicated by the recent SEC filing. However, there is limited publicly available information about his background and career, suggesting he may not be widely recognized in the public domain.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.18M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Botwood Nicholas A.J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.